Patients diagnosed with ODD from January 1, 2009, to January 1, 2016, were asked to participate in the study. All patients were seen at the Department of Ophthalmology at Rigshospitalet-Glostrup, Denmark. The patient exclusion criteria were best corrected visual acuity (BCVA) >logMAR 0.2, age <18 years, and presence of systemic disease that could affect optic nerve function. Exclusion criteria for individual eyes were localized eye or optic nerve disease other than ODD (e.g., optic neuritis, glaucoma, etc.) or ODD complications (e.g., drusen-associated anterior ischemic optic neuropathy, central retinal artery, vein occlusion, etc.) that could affect optic nerve function.
Informed consent was obtained from the subjects after explanation of the nature and possible consequences of the study. All procedures adhered to the tenets of Declaration of Helsinki.